Comparison of Surgery Versus Domestic- Made VSD Occluder Device Implantation. in the Closure of Ventricular Septal Defects

DAI Zheng-xue,GUAN Ying-min,CUI Xu-hui,ZHANG Yu-shun,WANG Hai-chang,JIA Guo-liang,LI Huan,LIU Jian-ping,ZHANG Jun,LI Jun,WANG Xiao-yan
DOI: https://doi.org/10.3969/j.issn.1009-7236.2005.02.027
2005-01-01
Abstract:AIM: To compare effectiveness, complications, and cost of domestic-made VSD occluder with surgical in ventricular septal defect (VSD) closure. METHODS: We prospectively compared closure rates, complication rates, cost, inpatient stay, and home convalescent time in 458 patients with ventricular septal defects: 215 cases (9±10 years) were treated surgically and 243 cases(8±11 years) were treated by percutaneous domestic-made VSD septal occluder. RESULTS: domestic-made VSD occluder closure was successful in 241 of 243 (99.1%) patients. Surgical closure was successful in all 215 cases. In domestic-made VSD septal occluder group, the left ventricular graphies(LVG) showed that 199(81.9%)patients had complete immediate closure, 44(18.1%)had a trace to small shunt immediately after the procedures;Within 24~48 h, color Doppler revealed complete closure in 223(91.8%) patients and a trace to small shunt in 20 patients (8.2%); 5 cases suffered with temporary Ⅲ° atrial ventricular block and returned to normal 4~10 days after medicines treatment;One patient developed hemolysis 24h after the procedure and recovered 7 days after medicines treatment; Doppler revealed that a trace to small shunt in 2 patients 1mo after the procedure. In surgical group, doppler revealed that a trace to small shunt in 2 patients 1mo after the procedure; 5 cases suffered with temporary Ⅲ°atrial ventricular block and returned to normal 4~10 days after medicines treatment;One patient developed hemolysis 24h after the procedure and recovered 7 days after medicines treatment.Blood products were administered to 86 patients in the surgical group and no patient in the device group (P0.01). Both hospital stay and home convalescent times were significantly shorter after domestic-made VSD occluder closure (median hospital stay: domestic-made VSD occluder 5 day, surgery 14 days; median convalescent time: domestic-made VSD occluder two weeks, surgery 6 weeks). Median cost was slightly higher in surgical groups (domestic-made VSD occluder RMB 2956±542, surgical RMB 2536±742, P0.05). CONSLUSION: Transcatheter closure of ventricular septal defects with the domestic-made VSD occluder device has the advantage of fewer complications, shorter hospitalization, and reduced need of blood products. Nonetheless, the surgeon's ability to close any ventricular septal defect regardless of its size or location remains an important advantage of surgery.
What problem does this paper attempt to address?